HealthCor Partners logo

HealthCor Partners

North America, South Carolina, United States, Charleston

Description

HealthCor Partners Management, L.P., commonly known as HealthCor Partners, is a distinguished private equity firm based in Charleston, United States, dedicated to growth equity investments within the healthcare sector. Operating as the private equity arm of HealthCor Management, L.P., the firm strategically targets commercial-stage healthcare companies that have demonstrated proven products or services and are poised for significant expansion. Their investment philosophy centers on providing substantial capital to accelerate growth, enhance market penetration, and support strategic initiatives for their portfolio companies.

The firm's investment strategy spans a broad range of healthcare sub-sectors, including biotechnology, medical devices, pharmaceuticals, and healthcare services. HealthCor Partners typically seeks to acquire significant minority or control positions, indicating a hands-on approach to value creation. Their typical first cheque size for new investments ranges from $25 million to $75 million per transaction. This substantial investment range underscores their focus on later-stage growth equity rounds, differentiating them from early-stage venture capital firms and enabling them to provide the necessary capital for companies to scale operations, expand product lines, or enter new markets.

HealthCor Partners has successfully raised considerable capital, affirming its strong presence in the healthcare investment landscape. The firm closed its inaugural fund, HealthCor Partners Fund, L.P., with $500 million in commitments in 2014. Building on this foundation, they subsequently closed their second fund, HealthCor Partners II, L.P., at $750 million in 2018, bringing their total capital raised across these two funds to $1.25 billion. These significant fund sizes allow HealthCor Partners to be a leading investor in the healthcare growth equity space, supporting a diverse portfolio of companies through their commercial development and contributing to successful exits, as seen with companies like Intersect ENT and Silk Road Medical.

Investor Profile

HealthCor Partners has backed more than 20 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 10% of its total and boasts 14 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States, France, Canada.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Typical check size: $25M – $75M.

Stage Focus

  • Series Unknown (25%)
  • Series B (20%)
  • Series C (10%)
  • Post Ipo Equity (10%)
  • Series F (10%)
  • Series D (5%)
  • Seed (5%)
  • Post Ipo Debt (5%)
  • Series E (5%)
  • Convertible Note (5%)

Country Focus

  • United States (85%)
  • France (5%)
  • Canada (5%)
  • United Kingdom (5%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Health Diagnostics
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Manufacturing
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HealthCor Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 3
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 2
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 3
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Marshall Wace
Europe, England, United Kingdom, London
Co-Investments: 2
U.S. Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 4
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 3

What are some of recent deals done by HealthCor Partners?

Heartflow

Mountain View, California, United States

Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical
Convertible NoteMar 26, 2025
Amount Raised: $98,000,000
HeartFlow

Mountain View, California, United States

HeartFlow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical
Series FApr 6, 2023
Amount Raised: $215,000,000
Karyopharm Therapeutics

Newton, Massachusetts, United States

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.

Health CareMedicalPharmaceutical
Post Ipo EquityDec 5, 2022
Amount Raised: $165,000,000
Mineralys Therapeutics

Radnor, Pennsylvania, United States

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BJun 8, 2022
Amount Raised: $118,000,000
DNA Script

Le Kremlin-bicêtre, Ile-de-France, France

DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.

BiotechnologyHealth CareLife ScienceMedical
Series CJan 4, 2022
Amount Raised: $200,000,000
Acrivon Therapeutics

Cambridge, Massachusetts, United States

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

BiotechnologyHealth CareOncologyTherapeutics
Series BNov 11, 2021
Amount Raised: $100,000,000
Imperative Care

Campbell, California, United States

Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.

Health CareMedicalMedical Device
Series DJul 15, 2021
Amount Raised: $260,000,000
Ikena Oncology

Boston, Massachusetts, United States

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics
Series BJan 5, 2021
Amount Raised: $120,000,000
Claret Medical

Santa Rosa, California, United States

Claret Medical develops cerebral vascular protection systems for Transcatheter Aortic Valve Implantation (TAVI) and other procedures.

Health CareMedicalMedical Device
Series COct 23, 2017
Amount Raised: $14,500,000
PreemaTEX

Great River, New York, United States

PreemaTEX is a developer of diagnostic tests to assess a woman’s risk for preterm delivery early in pregnancy.

Health CareHealth Diagnostics
Series UnknownOct 1, 2015